You are here

  • Home
  • Archive
  • Volume 2018, Issue
  • Management of a rhegmatogenous retinal detachment in a low-resource setting: treatment options when there is no vitreoretinal surgeon

Article Text

Article menu
Download PDFPDF
Global health
CASE REPORT
Management of a rhegmatogenous retinal detachment in a low-resource setting: treatment options when there is no vitreoretinal surgeon
  1. Elizabeth Emsley1,
  2. P J Steptoe2,
  3. Sunildath Cazabon3
  1. 1 St Paul’s Eye Unit, Royal Liverpool University Hospital, Liverpool, UK
  2. 2 Institute of Translational Medicine, University of Liverpool, Liverpool, UK
  3. 3 Westminster Eye Unit, Countess of Chester Hospital, Chester, UK
  1. Correspondence to Dr Elizabeth Emsley, elizabeth.emsley{at}gmail.com

Summary

We discuss the case of a 49-year-old soldier with a macula-on rhegmatogenous retinal detachment in Sierra Leone. The case highlights the challenge of accessing visually preserving ophthalmic specialist care in sub-Saharan Africa (SSA) for vitreoretinal (VR) disease. It highlights a shortage of VR surgeons in SSA, limited examination facilities, the larger issue of accessing specialist care urgently and the costs associated with accessing surgery out-of-country. It also identifies a shortage in epidemiological data on the issue which limits the assessment of the scale of the problem.

  • retina
  • macula
  • ophthalmology

https://doi.org/10.1136/bcr-2017-223389

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors EE and PS were both involved with the planning, conducting and reporting of this case. SC has been involved in the reporting of this case and has contributed significantly to the draft writing process.

    • Funding Steptoe funded by the Global Ophthalmology Awards Programme Grant supported by Bayer, the National Institute for Health Research - Protection Research Unit in Emerging and Zoonotic Infections, the BMA Humanitarian Fund and the Dowager Countess Eleanor Peel Trust outside of the submitted work

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.